Diamondback Drugs of Delaware Buprenorphine Hcl Pf (C) Injectable Strengths: 0.15 Mg/ml

Recall announced June 10, 2013 by Diamondback Drugs of Delaware, LLC, posted by the U.S. Food and Drug Administration (FDA). Reason: Diamondback Drugs is recalling Buprenorphine HCL PF (C) Injectable due to an issue with the long-term stability of the product. Use of the Buprenorphine HCL PF (C) Injectable may not deliver the level of therapeutic relief from pain as expected for compounding/compounded veterinary products. The agency has closed this recall.

Where sold
Nationwide in the US
Last updated
November 19, 2026

Products included

Read the official notice. Always compare the codes on your package with the official notice. It is the final word.

Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.

See all pet recalls